Table 1.
Comparison of Schistosoma haematobium–affected cases and their unaffected age- and sex-matched control group
Characteristic | Study subject group | ||
---|---|---|---|
77 cases with abnormal intake ultrasound exams | 77 matched controls with normal intake ultrasound exams | 95 with abnormal intake ultrasound exams—not followed | |
Mean age ± SD (range) | 27.7 ± 16.8 years (17–85) | 27.7 ± 16.7 years (17–85) | 31.2 ± 18.5 years (17–99) |
Percent male | 65 | 65 | 63 |
Infection prevalence, pre-Rx | 81% | 59%† | 62%* |
Infection prevalence, post-Rx | 26% | 19% | − |
Prevalence of heavy infection, pre-Rx | 22% | 9%* | 8%* |
Prevalence of heavy infection, post-Rx | 0% | 1% | − |
Rx = praziquantel treatment 40 mg/kg given once; SD = standard deviation.
Significant difference from the cases (ultrasound pathology group included in this report).
P < 0.04.
P < 0.01.